IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Aug 7, 2025 · 10-Q · 38 days after period end · 0000950170-25-105028
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$5.09M | -$8.63M | -$7.72M | -$7.18M |
| EPS Diluted | -$1.24 | -$5.51 | -$0.27 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end
